Status:
COMPLETED
I VACCIN Hospitalization of COVID-19 Patients
Lead Sponsor:
Eshmoun Clinical Research Center
Conditions:
SARS CoV 2 Infection
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
A REALLIFE evaluation of rate of hospitalized patients in Intensive Care Units and in medical Units of non -vaccinated patients vs vaccinated patients
Detailed Description
Transversal National multicenter non interventional on the COVID-19 vaccines * Period of hospitalization: from January 1st to March 3rd, 2022 * Recruitment duration: 37 days * Total study duration: 4...
Eligibility Criteria
Inclusion
- Male and Female ≥ 18 years
- Confirmed COVID-19 patients hospitalized in ICU and Medical Units during the period of the study from January 1st to March 3rd.
Exclusion
- Subjects vaccinated outside Tunisia
- Subjects \<18 years
- Not confirmed COVID-19
- Not hospitalized patients
Key Trial Info
Start Date :
January 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 10 2022
Estimated Enrollment :
1096 Patients enrolled
Trial Details
Trial ID
NCT05244343
Start Date
January 25 2022
End Date
March 10 2022
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abderrahmen Mami Hospital
Aryanah, Tunisia